Financial statements Artropharm

Balance sheet of Artropharm

Company age:
Age:
9 y. 6 m. 20 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of ARTROPHARM

Year
2017
2018
2019
2020
Total assets 644 755,88 732 558,90 644 755,88 644 755,88
A. Fixed assets 0,00 0,00 0,00 0,00
B. Current assets 644 755,88 732 558,90 644 755,88 644 755,88
C. Share capital contributions (basic funds) - - - -
D. Own shares (stocks) - - - -
Total liabilities 644 755,88 732 558,90 644 755,88 644 755,88
A. Equity 159 501,90 203 414,59 159 501,90 159 501,90
B. Liabilities and provisions for liabilities 485 253,98 529 144,31 485 253,98 485 253,98
I. Long-term liabilities - - - -
II. Short-term liabilities - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.